Last reviewed · How we verify
extended release of octreotide — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
extended release of octreotide (extended release of octreotide) — Chemi S.p.A..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| extended release of octreotide TARGET | extended release of octreotide | Chemi S.p.A. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- extended release of octreotide CI watch — RSS
- extended release of octreotide CI watch — Atom
- extended release of octreotide CI watch — JSON
- extended release of octreotide alone — RSS
Cite this brief
Drug Landscape (2026). extended release of octreotide — Competitive Intelligence Brief. https://druglandscape.com/ci/extended-release-of-octreotide. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab